The present findings appear relevant in the HBsAg-negative/anti-HBc-positive individuals undergoing immunosuppressive therapy or chemotherapy;6 the possibility to further stratify the risk of viral reactivation by means of com- bined antibody markers may be useful to tailor their manage- ment with HBV antivirals.
Quantitation of anti-HBe antibodies in anti-HBc-positive liver donors
Tandoi, Francesco;
2019-01-01
Abstract
The present findings appear relevant in the HBsAg-negative/anti-HBc-positive individuals undergoing immunosuppressive therapy or chemotherapy;6 the possibility to further stratify the risk of viral reactivation by means of com- bined antibody markers may be useful to tailor their manage- ment with HBV antivirals.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
